BECTON DICKINSON & CO — Director's Dealing 2023

Aug 9, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2023-08-08

Reporting Person: Garrison Michael David (EVP & President Medical)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-08	Common Stock	S	1300	$277.13	Disposed	5157	Direct

Footnotes

F1: The reported sale price reflects the weighted average sale price for two transactions. The actual sales prices for the transactions were $276.27 and $280.00. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.